2026-01-29 - Analysis Report
**Company Overview Analysis**

DuPont de Nemours is a multinational corporation providing a wide range of innovative products and solutions for various industries, including food, healthcare, and safety.

**Return Rate Comparison**

| Review Stock (DD) | Cumulative Return | Comparison Stock (VOO) | Cumulative Return |
|------------------|-------------------|------------------------|-------------------|
| 62.99%           | 128.51%          |

The review stock DD has a cumulative return of 62.99% while the comparison stock VOO has a cumulative return of 128.51%. This indicates a significant divergence between the two stocks.

**Divergence Analysis**

- Divergence (max: 17.70, min: -104.70, current: -65.60)
- Relative divergence: 31.90%

The current divergence between the review stock DD and the comparison stock VOO is -65.60, which is a moderate value. The relative divergence of 31.90% indicates that the current position is at the lower end of the past fluctuation range.

**Alpha, Beta Analysis**

| Year | CAGR | MDD | Alpha | Beta | Cap (B) |
|-----|------|-----|-------|------|---------|
| 2016-2018 | -5.0% | 24.7% | -14.0% | 1.1 | 13.3B |
| 2017-2019 | -37.0% | 24.7% | -62.0% | 1.2 | 11.2B |
| 2018-2020 | -33.0% | 56.2% | -57.0% | 1.2 | 12.5B |
| 2019-2021 | 23.0% | 56.2% | -41.0% | 1.1 | 14.2B |
| 2020-2022 | 37.0% | 45.0% | 32.0% | 1.1 | 12.0B |
| 2021-2023 | 0.0% | 32.7% | -18.0% | 1.1 | 13.5B |
| 2022-2024 | 4.0% | 31.3% | -25.0% | 1.0 | 13.4B |
| 2023-2025 | 36.0% | 34.6% | -39.0% | 1.1 | 16.8B |

The review stock DD's Alpha values range from -62.0% to 32.0%, while the Beta values range from 1.0 to 1.2. The CAGR values range from -37.0% to 37.0%.

**Recent Stock Price Fluctuations**

* Close: $44.62
* 5-day SMA: $44.27
* 20-day SMA: $43.05
* 60-day SMA: $40.81

The review stock DD's price has been steadily decreasing over the past 60 days, with a 5-day SMA and 20-day SMA lower than the current close price.

**RSI, PPO Index Indicators and Delta_Previous_Relative_Divergence, Expected_Return**

* Market Risk Indicator (MRI): 0.70
* RSI: 61.26
* PPO: 0.08
* Hybrid Signal: Buy (Cash 0%)
* Risk Level: Medium (MRI 0.70)
* Recent (20 days) relative divergence change: +2.10
* 7-day Rank change: -8
* 7-day Dynamic Expected Return change: +55.20

The review stock DD's MRI is 0.70, indicating a medium risk level. The RSI is 61.26, and the PPO is 0.08. The hybrid signal is buy (cash 0%). The recent relative divergence change is +2.10, and the 7-day rank change is -8.

**Expected Return**

* Expected Return: -121.60%
* Expected excess return compared to S&P 500 if invested long-term (more than 2 years) from this point.

The review stock DD's expected return is -121.60%.

**Recent News & Significant Events**

1. [2026-01-26] How DuPont is rewarding greener medical packaging with Tyvek awards - Stock Titan (news.google.com)
2. [2026-01-24] What DuPont de Nemours (DD)'s Board Addition of D.G. Macpherson Means For Shareholders - simplywall.st (news.google.com)
3. [2026-01-22] Is DuPont de Nemours (DD) Fairly Priced After 36% One Year Share Price Gain? - Yahoo Finance (news.google.com)
4. [2026-01-25] Newport Trust Company LLC Trims Stock Holdings in DuPont de Nemours, Inc. $DD - MarketBeat (news.google.com)
5. [2026-01-08] DuPont Slashes Dividend, And That Might Be Their Best Move For Sustainable Growth - Seeking Alpha (news.google.com)
6. [2026-01-22] DuPont de Nemours Inc (DD) Stock Price Up 3.46% on Jan 22 - GuruFocus (news.google.com)

The recent news and significant events for the review stock DD include the Tyvek awards, board addition of D.G. Macpherson, fair pricing, trimming of stock holdings, and slashing of dividend.

**Analyst Opinions**

Analyst Consensus:
- Key: Strong_Buy
- Mean (1=StrongBuy~5=Sell): 1.47 (~Strong Buy)
- Opinions: 16
- Target Price (avg/high/low): 49.19 / 56.00 / 44.00

The analyst consensus for the review stock DD is strong buy, with a mean rating of 1.47 and 16 opinions. The target price range is 49.19 to 56.00.

**Recent Earnings Analysis**

| Date | EPS | Revenue |
|-----|-----|---------|
| 2025-11-07 | 0.1 | 0.89 B$ |
| 2025-08-08 | 0.01 | 0.83 B$ |
| 2025-05-07 | 0.07 | 0.76 B$ |
| 2024-11-08 | 0.15 | 0.69 B$ |
| 2025-11-07 | 0.15 | 0.69 B$ |

The review stock DD's recent earnings have been declining, with the current EPS at 0.1 and revenue at 0.89 B$.

**Revenue and Profitability**

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-09-30 | $3.07B | 38.90% |
| 2025-06-30 | $3.26B | 37.33% |
| 2025-03-31 | $3.07B | 37.38% |
| 2024-12-31 | $3.09B | 36.38% |
| 2024-09-30 | $2.86B | 39.24% |

The review stock DD's revenue has been fluctuating, with a current value of $3.07B and profit margin of 38.90%.

**Capital and Profitability**

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-09-30 | $22.89B | -0.54% |
| 2025-06-30 | $23.06B | 0.26% |
| 2025-03-31 | $22.83B | -2.58% |
| 2024-12-31 | $23.35B | -0.51% |
| 2024-09-30 | $24.21B | 1.88% |

The review stock DD's equity has been increasing, with a current value of $22.89B. The return on equity (ROE) has been fluctuating, with a current value of -0.54%.

**Comprehensive Analysis**

The review stock DD has experienced a significant divergence between its own performance and that of the comparison stock VOO. The company's earnings have been declining, and the recent news and significant events have been mixed. The analyst consensus is strong buy, with a target price range of 49.19 to 56.00. The stock's capital and profitability have been fluctuating, with a current equity of $22.89B and ROE of -0.54%. The market risk indicator (MRI) is 0.70, indicating a medium risk level. Overall, the comprehensive analysis suggests that the review stock DD has a high level of uncertainty.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.